Logo image of 1BMRN.MI

BIOMARIN PHARMACEUTICAL INC (1BMRN.MI) Stock Price, Quote, News and Overview

BIT:1BMRN - Euronext Milan - US09061G1013 - Common Stock - Currency: EUR

52.36  -9.36 (-15.17%)

1BMRN.MI Quote, Performance and Key Statistics

BIOMARIN PHARMACEUTICAL INC

BIT:1BMRN (5/19/2025, 7:00:00 PM)

52.36

-9.36 (-15.17%)

Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryBiotechnology
Statistics
52 Week HighN/A
52 Week LowN/A
Market Cap9.98B
Shares190.58M
Float188.89M
Yearly DividendN/A
Dividend YieldN/A
PE34
Fwd PE19.48
Earnings (Next)02-20 2025-02-20/amc
IPO07-23 1999-07-23


1BMRN.MI short term performance overview.The bars show the price performance of 1BMRN.MI in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months

1BMRN.MI long term performance overview.The bars show the price performance of 1BMRN.MI in the last 1, 2 and 3 years. 1 year 2 years 3 years

The current stock price of 1BMRN.MI is 52.36 EUR.

BIOMARIN PHARMACEUTICAL INC / 1BMRN Daily stock chart

1BMRN.MI Competitors/Peers

The largest stocks on the EU markets in the "Biotechnology" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
4AB.DE ABBVIE INC 18.1 288.98B
AMG.DE AMGEN INC 13.39 131.60B
GIS.DE GILEAD SCIENCES INC 14.08 119.42B
VX1.DE VERTEX PHARMACEUTICALS INC N/A 100.90B
1REGN.MI REGENERON PHARMACEUTICALS 13.82 58.22B
ARGX.BR ARGENX SE 108.39 31.17B
22UA.DE BIONTECH SE-ADR N/A 20.94B
IDP.DE BIOGEN INC 8.14 16.61B
0QF.DE MODERNA INC N/A 9.21B
1MRNA.MI MODERNA INC N/A 8.79B
BIO.DE BIOTEST AG 65.85 1.69B
GLPG.AS GALAPAGOS NV N/A 1.69B

About 1BMRN.MI

Company Profile

1BMRN logo image BioMarin Pharmaceutical, Inc. engages in the development and commercialization of therapies for people with serious and life-threatening rare diseases and medical conditions. The company is headquartered in Novato, California and currently employs 3,401 full-time employees. BioMarin's commercial products include Vimizim (elosulfase alpha), Naglazyme (galsulfase), Palynziq (pegvaliase-pqpz), Brineura (cerliponase alfa), Aldurazyme (laronidase), Roctavian (valoctocogene roxaparvovec), Kuvan (sapropterin dihydrochloride), and Voxzogo (vosoritide). Vimizim is an enzyme replacement therapy for the treatment of MPS IVA, a lysosomal storage disorder. The Roctavian is an adeno associated virus (AAV5) vector gene therapy designed to restore factor VIII plasma concentrations in patients with severe hemophilia A. Voxzogo is a once daily injection analog of C-type Natriuretic Peptide (CNP) for the treatment of achondroplasia. Brineura is a recombinant human tripeptidyl peptidase 1 (TPP1) for the treatment of patients with CLN2, a form of Batten disease.

Company Info

BIOMARIN PHARMACEUTICAL INC

105 Digital Drive

Novato CALIFORNIA US

Employees: 3401

1BMRN Company Website

Phone: 14155056700

BIOMARIN PHARMACEUTICAL INC / 1BMRN.MI FAQ

What is the stock price of BIOMARIN PHARMACEUTICAL INC today?

The current stock price of 1BMRN.MI is 52.36 EUR. The price decreased by -15.17% in the last trading session.


What is the ticker symbol for BIOMARIN PHARMACEUTICAL INC stock?

The exchange symbol of BIOMARIN PHARMACEUTICAL INC is 1BMRN and it is listed on the Euronext Milan exchange.


On which exchange is 1BMRN.MI stock listed?

1BMRN.MI stock is listed on the Euronext Milan exchange.


What is the price forecast or stock price prediction for BIOMARIN PHARMACEUTICAL INC stock?

35 analysts have analysed 1BMRN.MI and the average price target is 93.14 EUR. This implies a price increase of 77.88% is expected in the next year compared to the current price of 52.36. Check the BIOMARIN PHARMACEUTICAL INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is BIOMARIN PHARMACEUTICAL INC worth?

BIOMARIN PHARMACEUTICAL INC (1BMRN.MI) has a market capitalization of 9.98B EUR. This makes 1BMRN.MI a Mid Cap stock.


How many employees does BIOMARIN PHARMACEUTICAL INC have?

BIOMARIN PHARMACEUTICAL INC (1BMRN.MI) currently has 3401 employees.


Is BIOMARIN PHARMACEUTICAL INC (1BMRN.MI) expected to grow?

The Revenue of BIOMARIN PHARMACEUTICAL INC (1BMRN.MI) is expected to grow by 17.05% in the next year. Check the estimates tab for more information on the 1BMRN.MI EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy BIOMARIN PHARMACEUTICAL INC (1BMRN.MI) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does BIOMARIN PHARMACEUTICAL INC (1BMRN.MI) stock pay dividends?

1BMRN.MI does not pay a dividend.


When does BIOMARIN PHARMACEUTICAL INC (1BMRN.MI) report earnings?

BIOMARIN PHARMACEUTICAL INC (1BMRN.MI) will report earnings on 2025-02-20, after the market close.


What is the Price/Earnings (PE) ratio of BIOMARIN PHARMACEUTICAL INC (1BMRN.MI)?

The PE ratio for BIOMARIN PHARMACEUTICAL INC (1BMRN.MI) is 34. This is based on the reported non-GAAP earnings per share of 1.54 and the current share price of 52.36 EUR. Check the full fundamental report for a full analysis of the valuation metrics for 1BMRN.MI.


1BMRN.MI Technical Analysis

ChartMill assigns a technical rating of 1 / 10 to 1BMRN.MI.


Chartmill TA Rating
Chartmill Setup Rating

1BMRN.MI Fundamental Analysis

ChartMill assigns a fundamental rating of 6 / 10 to 1BMRN.MI. While 1BMRN.MI has a great health rating, its profitability is only average at the moment.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

1BMRN.MI Financial Highlights

Over the last trailing twelve months 1BMRN.MI reported a non-GAAP Earnings per Share(EPS) of 1.54. The EPS increased by 127.27% compared to the year before.


Industry RankSector Rank
PM (TTM) 11.71%
ROA 4.7%
ROE 5.95%
Debt/Equity 0.11
Chartmill High Growth Momentum
EPS Q2Q%161.9%
Sales Q2Q%28.29%
EPS 1Y (TTM)127.27%
Revenue 1Y (TTM)19.14%

1BMRN.MI Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 79% to 1BMRN.MI. The Buy consensus is the average rating of analysts ratings from 35 analysts.

For the next year, analysts expect an EPS growth of 120.5% and a revenue growth 17.05% for 1BMRN.MI


Ownership
Inst OwnersN/A
Ins OwnersN/A
Short Float %N/A
Short RatioN/A
Analysts
Analysts78.86
Price Target93.14 (77.88%)
EPS Next Y120.5%
Revenue Next Year17.05%